FDA Investigator Gifford Whitehurst, Jr
Gifford Whitehurst, Jr has conducted inspections on 199 sites in 2 countries as of 25 Jan 2012. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
199
Last Inspection Date:
25 Jan 2012
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Gifford Whitehurst, Jr:
Abdellah El Hajjam,
Alice S Tsao,
Amos C Epps,
Amy A Johnson,
Amy C Amaro,
Andrew T Todd,
Arindam Dasgupta, PhD,
Asamoah Asamoah,
Ashley L Reiber,
Billingsley,
Brandon L Mariner,
Brian L Belz,
Brian R Yaun,
Brooke K Higgins,
Brooke K Seeman,
Burnell M Henry,
Byungja E Marciante,
Candice C Mandera,
Candice J Cortes,
Carol Rivera Lopez, PhD,
Caroline Strasinger,
Carrie L Doupnik,
Chaltu Nwakijra,
Charisse K Green,
Charlean R Butler,
Charles D Boison,
Charles M Kerns, BLT DO,
Charlotte E Wilkins,
Christine M O'leary,
Christopher M Henderson,
Christopher R Richardson,
Chryste D Best,
Clarice J Ahn,
Conrad M Guardia,
Cynthia A Harris, MD, RN,
David A Carlson,
David A Trent Carlson,
David L Chon,
David P Rice, Jr,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Dennis L Doupnik,
Deyaa Shaheen,
Dianne H Milazzo,
Dirk L Lincoln,
Douglas A Campbell,
Dr. Abhijit Raha, PhD,
Dr. Gang Wang, PhD,
Dr. Gopa Biswas, PhD,
Dr. Sriram Subramaniam, PhD,
Earl Echon,
Eileen A Liu,
Elise A Murphy,
Elvis D Morton,
Emest F Bizjak,
Emmanuel A Dimaano, Jr,
Eric L Dong, BS,
Erik T Nagaoka,
Erin L Mcfiren,
Esaw,
Fabian Nchaparro Rodriguez,
Gale L Glinecki,
George Pyramides,
Gerald D Bromley, Jr,
Gerald Mierle,
Heath A Gerber,
Helen B Ricalde,
Huixia Zhang,
Iram R Hassan, PhD,
Jacqueline A O'shaughnessy, PhD,
Jacqueline Johnson,
Jacqueline S Warner,
James M Simpson,
Jingbo Xiao,
Joey C West,
John A Kadavil, PhD,
John Dan,
Johnson,
Jonathan W Chapman,
Jose R Hernandez,
Joseph Maselli,
Joseph S Fanelli,
Kailee R Mason,
Karen A Briggs,
Karen A Spencer,
Kenneth L Smalls,
Kenneth Nieves,
Kerun Hardeo,
Kwong P Lee,
Kyle S Hobson,
La Tasham Gunter,
Latoya S Oliver Powell,
Laurianne M Montonye,
Lawrence Harmon, Jr,
LCDR Cornelius Brown, III,
LCDR Debra Emerson,
LCDR Matthew R Mcnew, MPH, REHS/RS,
LCDR Wilfred A Darang,
Lillian C Hsu,
Linda J Eason,
Lisa B Orr,
Lori S Lawless,
Luella J Rossi,
Luis A Dasta,
Marcus A Ray,
Marion W Nadeau,
Marla A Cassidy,
Martin K Yau, PhD,
Mary K Leslie,
Matthew A Spataro,
Melissa J Garcia,
Michael F Skelly, PhD,
Michael R Dominick,
Michael S Call,
Michael Serrano,
Mildred L Mccray,
Mohamad A Chahine,
Myra L Gemmill,
Nathaniel R Esaw,
Nebil A Oumer,
Paul Mouris,
Paula J Bretz,
Pelekakis,
Qin Xu,
Raymond W Niles,
Richard J Bashay,
Ruark Lanham,
Sam H Haidar, PhD,
Sam Pepe,
Samuel H Chan, PharmD,
Satheesh Thomas,
Sean R Moynihan, MPH,
Sean Y Kassim, PhD,
Sherry L Secrist, BLT DO,
Sierra M Shockley,
Simone E Pitts,
Slatten,
Srinivas R Chennamaneni, PhD,
Stacey A Priest,
Stephanie A Madison,
Stephanie Mangigian, MS/OSH, RN,
Stephen C Eason,
Susan J Essenmacher,
Susan M Jackson,
Sylvia R Dooling,
Tamal K Chakraborti, PhD,
Tamara N Champion,
Tania E Vizcaino,
Thomas J Hudson,
Thomas P Hansen,
Thomas R Withers,
Tiki J Dixon,
Toyin B Oladimeji,
Uduak M Inokon,
Vesna V Stanoyevitch,
William A Warnick,
William D Murray,
William H Linkroum,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Yih Chain Huang, PhD,
Zhongren Wu
Gifford Whitehurst, Jr's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| November, 2001 | FDA 483 Response | Bon Secours Home Medical - Form 483R, 2001-12-21 |
| November, 2001 | FDA 483 | Bon Secours Home Medical - Form 483, 2001-11-16 |
| November, 2001 | FDA 483 | Lincare Inc - Form 483, 2001-11-02 |
| November, 2001 | EIR | Lincare Inc - EIR, 2001-11-02 |
| May, 2010 | FDA 483 | Fareva Richmond, Inc. - Form 483, 2010-05-14 |
| August, 2001 | FDA 483 | Barr Laboratories Inc. - Form 483, 2001-08-30 |
| October, 2007 | FDA 483 | Med-Tech Repairs Inc. - Form 483, 2007-10-24 |
| July, 2001 | FDA 483 | PPD Development, L.P. - Form 483, 2001-07-26 |
| July, 2001 | EIR | PPD Development, L.P. - EIR, 2001-07-26 |
| November, 2001 | EIR | Bon Secours Home Medical - EIR, 2001-11-16 |
| March, 2000 | EIR | Sankyo U.S.A. Development( Div. of Sankyo Pharma, Inc.) - EIR, 2000-03-30 |
| January, 2009 | EIR | Tidewater Blanching Corp - EIR, 2009-01-26 |
| June, 2008 | FDA 483 | Linde Gas & Equipment Inc. - Form 483, 2008-06-25 |
| June, 2001 | FDA 483 | Fareva Richmond, Inc. - Form 483, 2001-06-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more